Portfolio
Funding for TripleMed to achieve CE marking
21.03.2024
Our progress journal.
Portfolio
Matisse Pharmaceuticals meets primary objectives in study with M6229 in critically ill sepsis patients
30.01.2024
Portfolio
Verdify secures €2.4 million investment for impactful food choices in healthcare and retail
24.01.2024
Portfolio
Funding of Ioniqa’s enhanced recycling business of PET Polyester
23.01.2024
Portfolio
Qorium lands additional funds from Brightlands Venture Partners and Sofinnova Partners
10.01.2024
Portfolio
AGI Group Acquires Chemtrix B.V. to Expand into the Large-scale Flow Chemistry Market
04.01.2024
Portfolio
Matisse Pharmaceuticals closes €3.6M financing round
04.01.2024
Portfolio
Corporis Medical closes €4M Series B financing round
07.12.2023